Literature DB >> 22560909

Low-density lipoprotein-independent improvement of flow-mediated dilatation with atorvastatin: a meta-analysis and meta-regression of randomized controlled trials.

Hisato Takagi, Hirotaka Yamamoto, Kotaro Iwata, Shin-Nosuke Goto, Takuya Umemoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22560909     DOI： 10.1016/j.ijcard.2012.04.054

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

Review 1.  Mechanisms and Clinical Implications of Endothelial Dysfunction in Arterial Hypertension.

Authors:  Pasquale Ambrosino; Tiziana Bachetti; Silvestro Ennio D'Anna; Brurya Galloway; Andrea Bianco; Vito D'Agnano; Antimo Papa; Andrea Motta; Fabio Perrotta; Mauro Maniscalco
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-27

2.  A Randomized Controlled Trial Comparing the Effects of Sitagliptin and Glimepiride on Endothelial Function and Metabolic Parameters: Sapporo Athero-Incretin Study 1 (SAIS1).

Authors:  Hiroshi Nomoto; Hideaki Miyoshi; Tomoo Furumoto; Koji Oba; Hiroyuki Tsutsui; Atsushi Inoue; Tatsuya Atsumi; Naoki Manda; Yoshio Kurihara; Shin Aoki
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

3.  A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2).

Authors:  Hiroshi Nomoto; Hideaki Miyoshi; Tomoo Furumoto; Koji Oba; Hiroyuki Tsutsui; Arina Miyoshi; Takuma Kondo; Kenichi Tsuchida; Tatsuya Atsumi; Naoki Manda; Yoshio Kurihara; Shin Aoki
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

4.  The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3).

Authors:  Naoyuki Kitao; Hideaki Miyoshi; Tomoo Furumoto; Kota Ono; Hiroshi Nomoto; Aika Miya; Chiho Yamamoto; Atsushi Inoue; Kenichi Tsuchida; Naoki Manda; Yoshio Kurihara; Shin Aoki; Akinobu Nakamura; Tatsuya Atsumi
Journal:  Cardiovasc Diabetol       Date:  2017-10-10       Impact factor: 9.951
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.